SCHEMBL7403186

SCHEMBL7403186

CCCC(=O)OC1=CCCc2ccccc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD1 P21728 3/20 0.42
HTR2A P28223 3/20 0.42
DRD2 P14416 2/20 0.42
HTR1A P08908 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.41
LMNA P02545 3/20 0.40
GAA P10253 1/20 0.40
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
ALDH1A1 P00352 3/20 0.38
KMT2A Q03164 3/20 0.37
L3MBTL1 Q9Y468 3/20 0.36
MEN1 O00255 2/20 0.36
KDM4E B2RXH2 1/20 0.36
HPGD P15428 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
PDGFRB P09619 1/20 0.36
PDGFRA P16234 1/20 0.36
MAPT P10636 3/20 0.36
BCL9 O00512 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23581472 0.85 KDM4E (0.41) SMN1; SMN2ALDH1A1KMT2AL3MBTL1MEN1
SCHEMBL8500693 0.81 MAPT (0.44) DRD1DRD2SMN1; SMN2LMNANPC1
SCHEMBL27799151 0.80 HTR1A (0.35) DRD1HTR2ADRD2HTR1ALMNA
SCHEMBL27584431 0.78 MAPT (0.38) SMN1; SMN2LMNANPC1ALDH1A1KMT2A
SCHEMBL27532472 0.76 MAPT (0.46) SMN1; SMN2LMNAGAANPC1ALDH1A1
SCHEMBL13160775 0.75 MAPT (0.35) SMN1; SMN2LMNAGAAALDH1A1KMT2A
SCHEMBL27602229 0.74 MAPT (0.43) SMN1; SMN2LMNAGAANPC1RAB9A
SCHEMBL8927841 0.74 SMN1; SMN2 (0.40) DRD1HTR2ADRD2HTR1ASMN1; SMN2
SCHEMBL1182305 0.73 MAPT (0.42) SMN1; SMN2LMNANPC1RAB9AALDH1A1
SCHEMBL27481662 0.72 CES1 (0.36) SMN1; SMN2LMNAGAANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101429125-A Synthesis of (7-methoxy-3, 4-dihydrogen-1-naphthyl) ethyl acetate SHANGHAI INST PHARM INDUSTRY (CN) 2009-05-13 CN disclosed
US-6133446-A Heterocyclic compounds for the treatment of CNS and cardiovascular disorders PHARMACIA & UPJOHN COMPANY (US) 2000-10-17 US disclosed
CN-1046507-C Heterocyclic compounds for the treatment of central nervous system and cardiovascular diseases UPJOHN CO (US) 1999-11-17 CN disclosed
US-5877317-A Heterocyclic compounds for the treatment of CNS and cardiovascular disorders PHARMACIA & UPJOHN COMPANY (US) 1999-03-02 US disclosed
CN-1139431-A Heterocyclic compounds for the treatment of central nervous system and cardiovascular diseases PHARMACIA & UPJOHN CO LLC (US) 1997-01-01 CN disclosed
WO-1995018118-A1 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS THE UPJOHN COMPANY (US) 1995-07-06 WO disclosed